{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:59:57Z","timestamp":1789397997333,"version":"build-2803163510"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41390-021-01445-2","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T16:03:38Z","timestamp":1615997018000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Treg-associated monogenic autoimmune disorders and gut microbial dysbiosis"],"prefix":"10.1038","volume":"91","author":[{"given":"Yuying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Freeborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabba A.","family":"Armbrister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat Q.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Marc","family":"Rhoads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"1445_CR1","unstructured":"Anaya, J. M., Shoenfeld, Y., Rojas-Villarrage, A. & Cervera R. Autoimmunity. From Bench to Bedside (Rosario University Press, 2013)."},{"key":"1445_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376\u2013381 (2014).","journal-title":"Nature"},{"key":"1445_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/BOR.0000000000000086","volume":"26","author":"Y Deng","year":"2014","unstructured":"Deng, Y. & Tsao, B. P. Advances in lupus genetics and epigenetics. Curr. Opin. Rheumatol. 26, 482\u2013492 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1445_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04365-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa, Y. et al. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nat. Commun. 9, 2427 (2018).","journal-title":"Nat. Commun."},{"key":"1445_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","volume":"99","author":"L Amaya-Uribe","year":"2019","unstructured":"Amaya-Uribe, L., Rojas, M., Azizi, G., Anaya, J. M. & Gershwin, M. E. Primary immunodeficiency and autoimmunity: a comprehensive review. J. Autoimmun. 99, 52\u201372 (2019).","journal-title":"J. Autoimmun."},{"key":"1445_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fped.2019.00295","volume":"7","author":"R Castagnoli","year":"2019","unstructured":"Castagnoli, R., Delmonte, O. M., Calzoni, E. & Notarangelo, L. D. Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives. Front. Pediatr. 7, 295 (2019).","journal-title":"Front. Pediatr."},{"key":"1445_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41579-019-0191-8","volume":"17","author":"ED Sonnenburg","year":"2019","unstructured":"Sonnenburg, E. D. & Sonnenburg, J. L. The ancestral and industrialized gut microbiota and implications for human health. Nat. Rev. Microbiol. 17, 383\u2013390 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"1445_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451\u2013455 (2013).","journal-title":"Nature"},{"key":"1445_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446\u2013450 (2013).","journal-title":"Nature"},{"key":"1445_CR10","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.1073\/pnas.0909122107","volume":"107","author":"JL Round","year":"2010","unstructured":"Round, J. L. & Mazmanian, S. K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA 107, 12204\u201312209 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1445_CR11","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.3389\/fimmu.2019.02494","volume":"10","author":"T Ruohtula","year":"2019","unstructured":"Ruohtula, T. et al. Maturation of gut microbiota and circulating regulatory T cells and development of IgE sensitization in early life. Front. Immunol. 10, 2494 (2019).","journal-title":"Front. Immunol."},{"key":"1445_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"1445_CR13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","volume":"159","author":"JK Goodrich","year":"2014","unstructured":"Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789\u2013799 (2014).","journal-title":"Cell"},{"key":"1445_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature13788","volume":"516","author":"JR Lukens","year":"2014","unstructured":"Lukens, J. R. et al. Dietary modulation of the microbiome affects autoinflammatory disease. Nature 516, 246\u2013249 (2014).","journal-title":"Nature"},{"key":"1445_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.chom.2007.06.010","volume":"2","author":"C Lupp","year":"2007","unstructured":"Lupp, C. et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 119\u2013129 (2007).","journal-title":"Cell Host Microbe"},{"key":"1445_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/annrheumdis-2019-215743","volume":"79","author":"T Kishikawa","year":"2020","unstructured":"Kishikawa, T. et al. Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population. Ann. Rheum. Dis. 79, 103\u2013111 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1445_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0283-6","volume":"51","author":"Y Maeda","year":"2019","unstructured":"Maeda, Y. & Takeda, K. Host-microbiota interactions in rheumatoid arthritis. Exp. Mol. Med. 51, 1\u20136 (2019).","journal-title":"Exp. Mol. Med."},{"key":"1445_CR18","doi-asserted-by":"crossref","unstructured":"Durazzo, M., Ferro, A. & Gruden, G. Gastrointestinal microbiota and type 1 diabetes mellitus: the state of art. J. Clin. Med. 8, 1843 (2019).","DOI":"10.3390\/jcm8111843"},{"key":"1445_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41575-019-0242-7","volume":"17","author":"RM Thomas","year":"2020","unstructured":"Thomas, R. M. & Jobin, C. Microbiota in pancreatic health and disease: the next frontier in microbiome research. Nat. Rev. Gastroenterol. Hepatol. 17, 53\u201364 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1445_CR20","doi-asserted-by":"crossref","unstructured":"Kim, J. W., Kwok, S. K., Choe, J. Y. & Park, S. H. Recent advances in our understanding of the link between the intestinal microbiota and systemic lupus erythematosus. Int. J. Mol. Sci. 20, 4871 (2019).","DOI":"10.3390\/ijms20194871"},{"key":"1445_CR21","doi-asserted-by":"publisher","unstructured":"Brown, J., Quattrochi B., Everett, C., Hong, B. Y. & Cervantes, J. Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis. Mult. Scler. https:\/\/doi.org\/10.1177\/352458520928301 (2020).","DOI":"10.1177\/352458520928301"},{"key":"1445_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fimmu.2019.00385","volume":"10","author":"B He","year":"2019","unstructured":"He, B. et al. Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota. Front Immunol. 10, 385 (2019).","journal-title":"Front Immunol."},{"key":"1445_CR23","doi-asserted-by":"crossref","unstructured":"Kadowaki, A. & Quintana, F. J. The gut-CNS axis in multiple sclerosis. Trends Neurosci. 43, 622\u2013634 (2020).","DOI":"10.1016\/j.tins.2020.06.002"},{"key":"1445_CR24","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/17474124.2018.1517044","volume":"12","author":"B Balakrishnan","year":"2018","unstructured":"Balakrishnan, B. & Taneja, V. Microbial modulation of the gut microbiome for treating autoimmune diseases. Expert. Rev. Gastroenterol. Hepatol. 12, 985\u2013996 (2018).","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"1445_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ncp.10489","volume":"35","author":"R Vangoitsenhoven","year":"2020","unstructured":"Vangoitsenhoven, R. & Cresci, G. A. M. Role of microbiome and antibiotics in autoimmune diseases. Nutr. Clin. Pract. 35, 406\u2013416 (2020).","journal-title":"Nutr. Clin. Pract."},{"key":"1445_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrrheum.2017.198","volume":"14","author":"RE Schmidt","year":"2017","unstructured":"Schmidt, R. E., Grimbacher, B. & Witte, T. Autoimmunity and primary immunodeficiency: two sides of the same coin? Nat. Rev. Rheumatol. 14, 7\u201318 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1445_CR27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.1884","volume":"11","author":"W Ouyang","year":"2010","unstructured":"Ouyang, W. et al. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11, 618\u2013627 (2010).","journal-title":"Nat. Immunol."},{"key":"1445_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20\u201321 (2001).","journal-title":"Nat. Genet."},{"key":"1445_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/00008480-200112000-00007","volume":"13","author":"CL Bennett","year":"2001","unstructured":"Bennett, C. L. & Ochs, H. D. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr. Opin. Pediatr. 13, 533\u2013538 (2001).","journal-title":"Curr. Opin. Pediatr."},{"key":"1445_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2133.2008.08835.x","volume":"160","author":"M Halabi-Tawil","year":"2009","unstructured":"Halabi-Tawil, M. et al. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br. J. Dermatol. 160, 645\u2013651 (2009).","journal-title":"Br. J. Dermatol."},{"key":"1445_CR31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.autrev.2018.05.001","volume":"17","author":"G Azizi","year":"2018","unstructured":"Azizi, G. et al. Monogenic polyautoimmunity in primary immunodeficiency diseases. Autoimmun. Rev. 17, 1028\u20131039 (2018).","journal-title":"Autoimmun. Rev."},{"key":"1445_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fped.2019.00451","volume":"7","author":"MH Albert","year":"2019","unstructured":"Albert, M. H. & Freeman, A. F. Wiskott-Aldrich syndrome (WAS) and dedicator of cytokinesis 8- (DOCK8) deficiency. Front. Pediatr. 7, 451 (2019).","journal-title":"Front. Pediatr."},{"key":"1445_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10875-017-0453-z","volume":"38","author":"F Candotti","year":"2018","unstructured":"Candotti, F. Clinical manifestations and pathophysiological mechanisms of the Wiskott-Aldrich syndrome. J. Clin. Immunol. 38, 13\u201327 (2018).","journal-title":"J. Clin. Immunol."},{"key":"1445_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-3-030-21855-3_27","volume":"2","author":"MA El-Darouti","year":"2019","unstructured":"El-Darouti, M. A. & Al-Ali, F. M. Alopecia, nail dystrophy, vitiligo, and hypoparathyroidism. Challenging Cases Dermatol. 2, 199\u2013206 (2019).","journal-title":"Challenging Cases Dermatol."},{"key":"1445_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.dsi.2011.05.002","volume":"29","author":"C Hsu","year":"2011","unstructured":"Hsu, C., Lee, J. Y. Y. & Chao, S. C. Omenn syndrome: a case report and review of literature. Dermatol. Sin. 29, 50\u201354 (2011).","journal-title":"Dermatol. Sin."},{"key":"1445_CR36","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1182\/blood.V87.5.1663.1663","volume":"87","author":"D Roos","year":"1996","unstructured":"Roos, D. et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87, 1663\u20131681 (1996).","journal-title":"Blood"},{"key":"1445_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12311-5","volume":"10","author":"AJ Takeda","year":"2019","unstructured":"Takeda, A. J. et al. Human PI3Kgamma deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology. Nat. Commun. 10, 4364 (2019).","journal-title":"Nat. Commun."},{"key":"1445_CR38","doi-asserted-by":"publisher","first-page":"a007294","DOI":"10.1101\/cshperspect.a007294","volume":"5","author":"AV Chervonsky","year":"2013","unstructured":"Chervonsky, A. V. Microbiota and autoimmunity. Cold Spring Harb. Perspect. Biol. 5, a007294 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1445_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/CMR.00046-08","volume":"22","author":"TH Mogensen","year":"2009","unstructured":"Mogensen, T. H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22, 240\u2013273 (2009). Table.","journal-title":"Clin. Microbiol. Rev."},{"key":"1445_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ni.1801","volume":"11","author":"AV Chervonsky","year":"2010","unstructured":"Chervonsky, A. V. Influence of microbial environment on autoimmunity. Nat. Immunol. 11, 28\u201335 (2010).","journal-title":"Nat. Immunol."},{"key":"1445_CR41","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank, D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA 104, 13780\u201313785 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1445_CR42","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn\u2019s disease. Cell Host Microbe 15, 382\u2013392 (2014).","journal-title":"Cell Host Microbe"},{"key":"1445_CR43","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1172\/JCI44632","volume":"121","author":"B Chassaing","year":"2011","unstructured":"Chassaing, B. et al. Crohn disease-associated adherent-invasive E. coli bacteria target mouse and human Peyer\u2019s patches via long polar fimbriae. J. Clin. Invest. 121, 966\u2013975 (2011).","journal-title":"J. Clin. Invest."},{"key":"1445_CR44","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00000478-200302000-00011","volume":"27","author":"LW Lamps","year":"2003","unstructured":"Lamps, L. W. et al. Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn\u2019s disease. Am. J. Surg. Pathol. 27, 220\u2013227 (2003).","journal-title":"Am. J. Surg. Pathol."},{"key":"1445_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3109\/15513815.2013.768744","volume":"32","author":"SB Leu","year":"2013","unstructured":"Leu, S. B. et al. Pathogenic Yersinia DNA in intestinal specimens of pediatric patients with Crohn\u2019s disease. Fetal Pediatr. Pathol. 32, 367\u2013370 (2013).","journal-title":"Fetal Pediatr. Pathol."},{"key":"1445_CR46","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.3748\/wjg.v16.i39.4892","volume":"16","author":"U Navaneethan","year":"2010","unstructured":"Navaneethan, U., Venkatesh, P. G. & Shen, B. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J. Gastroenterol. 16, 4892\u20134904 (2010).","journal-title":"World J. Gastroenterol."},{"key":"1445_CR47","doi-asserted-by":"publisher","first-page":"18193","DOI":"10.1073\/pnas.0709160104","volume":"104","author":"DH Gray","year":"2007","unstructured":"Gray, D. H., Gavanescu, I., Benoist, C. & Mathis, D. Danger-free autoimmune disease in Aire-deficient mice. Proc. Natl Acad. Sci. USA 104, 18193\u201318198 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1445_CR48","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1084\/jem.20101235","volume":"207","author":"T Chinen","year":"2010","unstructured":"Chinen, T., Volchkov, P. Y., Chervonsky, A. V. & Rudensky, A. Y. A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota. J. Exp. Med. 207, 2323\u20132330 (2010).","journal-title":"J. Exp. Med."},{"key":"1445_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1084\/jem.20160961","volume":"214","author":"B He","year":"2017","unstructured":"He, B. et al. Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors. J. Exp. Med. 214, 107\u2013123 (2017).","journal-title":"J. Exp. Med."},{"key":"1445_CR50","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.immuni.2014.05.016","volume":"41","author":"S Kawamoto","year":"2014","unstructured":"Kawamoto, S. et al. Foxp3(+) T cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis. Immunity 41, 152\u2013165 (2014).","journal-title":"Immunity"},{"key":"1445_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.gastro.2015.05.009","volume":"149","author":"J Dobes","year":"2015","unstructured":"Dobes, J. et al. Gastrointestinal autoimmunity associated with loss of central tolerance to enteric alpha-defensins. Gastroenterology 149, 139\u2013150 (2015).","journal-title":"Gastroenterology"},{"key":"1445_CR52","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.4049\/jimmunol.1500301","volume":"196","author":"I Hetemaki","year":"2016","unstructured":"Hetemaki, I. et al. Anticommensal responses are associated with regulatory T cell defect in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. J. Immunol. 196, 2955\u20132964 (2016).","journal-title":"J. Immunol."},{"key":"1445_CR53","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/ismej.2014.165","volume":"9","author":"H Zhang","year":"2015","unstructured":"Zhang, H., Sparks, J. B., Karyala, S. V., Settlage, R. & Luo, X. M. Host adaptive immunity alters gut microbiota. ISME J. 9, 770\u2013781 (2015).","journal-title":"ISME J."},{"key":"1445_CR54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1084\/jem.20151116","volume":"213","author":"R Rigoni","year":"2016","unstructured":"Rigoni, R. et al. Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects. J. Exp. Med. 213, 355\u2013375 (2016).","journal-title":"J. Exp. Med."},{"key":"1445_CR55","doi-asserted-by":"publisher","first-page":"e12805","DOI":"10.1111\/sji.12805","volume":"91","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Li, Y. Y., Tang, X. & Zhao, X. Faecal microbial dysbiosis in children with Wiskott-Aldrich syndrome. Scand. J. Immunol. 91, e12805 (2020).","journal-title":"Scand. J. Immunol."},{"key":"1445_CR56","doi-asserted-by":"publisher","first-page":"8544","DOI":"10.3748\/wjg.v23.i48.8544","volume":"23","author":"T Ohya","year":"2017","unstructured":"Ohya, T. et al. Childhood-onset inflammatory bowel diseases associated with mutation of Wiskott-Aldrich syndrome protein gene. World J. Gastroenterol. 23, 8544\u20138552 (2017).","journal-title":"World J. Gastroenterol."},{"key":"1445_CR57","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/QCO.0b013e32832a8a5d","volume":"22","author":"CD Packey","year":"2009","unstructured":"Packey, C. D. & Sartor, R. B. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr. Opin. Infect. Dis. 22, 292\u2013301 (2009).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"1445_CR58","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1101\/gr.159467.113","volume":"23","author":"J Oh","year":"2013","unstructured":"Oh, J. et al. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res. 23, 2103\u20132114 (2013).","journal-title":"Genome Res."},{"key":"1445_CR59","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jcmgh.2015.06.010","volume":"1","author":"JR Kelsen","year":"2015","unstructured":"Kelsen, J. R., Baldassano, R. N., Artis, D. & Sonnenberg, G. F. Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease. Cell Mol. Gastroenterol. Hepatol. 1, 462\u2013476 (2015).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1445_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14275-y","volume":"11","author":"EG Serra","year":"2020","unstructured":"Serra, E. G. et al. Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease. Nat. Commun. 11, 995 (2020).","journal-title":"Nat. Commun."},{"key":"1445_CR61","doi-asserted-by":"publisher","first-page":"11971","DOI":"10.1073\/pnas.1002601107","volume":"107","author":"MG Dominguez-Bello","year":"2010","unstructured":"Dominguez-Bello, M. G. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. USA 107, 11971\u201311975 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1445_CR62","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/ecco-jcc\/jjy068","volume":"12","author":"F Charbit-Henrion","year":"2018","unstructured":"Charbit-Henrion, F. et al. Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: a multicentre study. J. Crohns Colitis 12, 1104\u20131112 (2018).","journal-title":"J. Crohns Colitis"},{"key":"1445_CR63","doi-asserted-by":"publisher","first-page":"17686","DOI":"10.1073\/pnas.1012016107","volume":"107","author":"MD Kraaij","year":"2010","unstructured":"Kraaij, M. D. et al. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc. Natl Acad. Sci. USA 107, 17686\u201317691 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1445_CR64","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/mi.2017.74","volume":"11","author":"T Schwerd","year":"2018","unstructured":"Schwerd, T. et al. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunol. 11, 562\u2013574 (2018).","journal-title":"Mucosal Immunol."},{"key":"1445_CR65","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jaci.2018.09.021","volume":"143","author":"H Sokol","year":"2019","unstructured":"Sokol, H. et al. Intestinal dysbiosis in inflammatory bowel disease associated with primary immunodeficiency. J. Allergy Clin. Immunol. 143, 775\u2013778 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1445_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0580-z","volume":"10","author":"EL Clarke","year":"2018","unstructured":"Clarke, E. L. et al. T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency. Genome Med. 10, 70 (2018).","journal-title":"Genome Med."},{"key":"1445_CR67","first-page":"237ra65","volume":"6","author":"K Aagaard","year":"2014","unstructured":"Aagaard, K. et al. The placenta harbors a unique microbiome. Sci. Transl. Med. 6, 237ra65 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1445_CR68","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1038\/cti.2016.38","volume":"5","author":"AT Vieira","year":"2016","unstructured":"Vieira, A. T., Fukumori, C. & Ferreira, C. M. New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases. Clin. Transl. Immunol. 5, e87 (2016).","journal-title":"Clin. Transl. Immunol."},{"key":"1445_CR69","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K. & Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220\u2013230 (2012).","journal-title":"Nature"},{"key":"1445_CR70","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/ismej.2010.118","volume":"5","author":"AW Walker","year":"2011","unstructured":"Walker, A. W. et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 5, 220\u2013230 (2011).","journal-title":"ISME J."},{"key":"1445_CR71","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill, C. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506\u2013514 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl. 10","key":"1445_CR72","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1002\/jcph.1121","volume":"58","author":"Y Liu","year":"2018","unstructured":"Liu, Y., Tran, D. Q. & Rhoads, J. M. Probiotics in disease prevention and treatment. J. Clin. Pharm. 58(Suppl. 10), S164\u2013S179 (2018).","journal-title":"J. Clin. Pharm."},{"key":"1445_CR73","doi-asserted-by":"crossref","unstructured":"Liu, Y., Alookaran, J. J. & Rhoads, J. M. Probiotics in autoimmune and inflammatory disorders. Nutrients 10, 1537 (2018).","DOI":"10.3390\/nu10101537"},{"key":"1445_CR74","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/MIB.0000000000000389","volume":"21","author":"C Strisciuglio","year":"2015","unstructured":"Strisciuglio, C. et al. Bifidobacteria enhance antigen sampling and processing by dendritic cells in pediatric inflammatory bowel disease. Inflamm. Bowel. Dis. 21, 1491\u20131498 (2015).","journal-title":"Inflamm. Bowel. Dis."},{"key":"1445_CR75","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/5584_2018_317","volume":"1125","author":"G Serena","year":"2019","unstructured":"Serena, G. & Fasano, A. Use of probiotics to prevent celiac disease and IBD in pediatrics. Adv. Exp. Med. Biol. 1125, 69\u201381 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1445_CR76","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/MPG.0000000000001896","volume":"66","author":"E Miele","year":"2018","unstructured":"Miele, E. et al. Nutrition in pediatric inflammatory bowel disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 66, 687\u2013708 (2018).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"1445_CR77","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1542\/peds.2010-0433","volume":"126","author":"F Savino","year":"2010","unstructured":"Savino, F. et al. Lactobacillus reuteri DSM 17938 in infantile colic: a Randomized, Double-Blind, Placebo-Controlled Trial. Pediatrics 126, e526\u2013e533 (2010).","journal-title":"Pediatrics"},{"key":"1445_CR78","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jped.2014.10.009","volume":"91","author":"EC Dinleyici","year":"2015","unstructured":"Dinleyici, E. C. et al. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. J. Pediatr. 91, 392\u2013396 (2015).","journal-title":"J. Pediatr."},{"key":"1445_CR79","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jpeds.2017.07.036","volume":"191","author":"NY Fatheree","year":"2017","unstructured":"Fatheree, N. Y. et al. Lactobacillus reuteri for infants with colic: a Double-Blind, Placebo-Controlled, Randomized Clinical Trial. J. Pediatr. 191, 170\u2013178 (2017).","journal-title":"J. Pediatr."},{"key":"1445_CR80","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fimmu.2014.00304","volume":"5","author":"A Ohta","year":"2014","unstructured":"Ohta, A. & Sitkovsky, M. Extracellular adenosine-mediated modulation of regulatory T cells. Front. Immunol. 5, 304 (2014).","journal-title":"Front. Immunol."},{"key":"1445_CR81","doi-asserted-by":"publisher","first-page":"C530","DOI":"10.1152\/ajpcell.00385.2010","volume":"301","author":"M Romio","year":"2011","unstructured":"Romio, M. et al. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. Am. J. Physiol. Cell Physiol. 301, C530\u2013C539 (2011).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1445_CR82","doi-asserted-by":"publisher","first-page":"G824","DOI":"10.1152\/ajpgi.00107.2019","volume":"317","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Lactobacillus reuteri DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites. Am. J. Physiol. Gastrointest. Liver Physiol. 317, G824\u2013G838 (2019).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1445_CR83","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","volume":"19","author":"L Antonioli","year":"2013","unstructured":"Antonioli, L., Pacher, P., Vizi, E. S. & Hasko, G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 19, 355\u2013367 (2013).","journal-title":"Trends Mol. Med."},{"key":"1445_CR84","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3389\/fimmu.2017.01680","volume":"8","author":"B He","year":"2017","unstructured":"He, B., Hoang, T. K., Tran, D. Q., Rhoads, J. M. & Liu, Y. Adenosine A2A receptor deletion blocks the beneficial effects of Lactobacillus reuteri in regulatory T-deficient scurfy mice. Front. Immunol. 8, 1680 (2017).","journal-title":"Front. Immunol."},{"key":"1445_CR85","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.jaci.2018.03.015","volume":"142","author":"FR Santoni de Sio","year":"2018","unstructured":"Santoni de Sio, F. R. et al. Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis. J. Allergy Clin. Immunol. 142, 1909\u20131921 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1445_CR86","doi-asserted-by":"publisher","first-page":"eaaz0571","DOI":"10.1126\/sciadv.aaz0571","volume":"6","author":"M Goodwin","year":"2020","unstructured":"Goodwin, M. et al. CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells. Sci. Adv. 6, eaaz0571 (2020).","journal-title":"Sci. Adv."},{"key":"1445_CR87","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1172\/JCI25112","volume":"116","author":"R Bacchetta","year":"2006","unstructured":"Bacchetta, R. et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116, 1713\u20131722 (2006).","journal-title":"J. Clin. Invest."},{"key":"1445_CR88","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13011","volume":"1417","author":"R Bacchetta","year":"2018","unstructured":"Bacchetta, R., Barzaghi, F. & Roncarolo, M. G. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann. NY Acad. Sci. 1417, 5\u201322 (2018).","journal-title":"Ann. NY Acad. Sci."},{"key":"1445_CR89","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.4049\/jimmunol.153.8.3764","volume":"153","author":"PJ Blair","year":"1994","unstructured":"Blair, P. J. et al. CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J. Immunol. 153, 3764\u20133774 (1994).","journal-title":"J. Immunol."},{"key":"1445_CR90","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/eji.201242391","volume":"42","author":"TJ Suscovich","year":"2012","unstructured":"Suscovich, T. J., Perdue, N. R. & Campbell, D. J. Type-1 immunity drives early lethality in scurfy mice. Eur. J. Immunol. 42, 2305\u20132310 (2012).","journal-title":"Eur. J. Immunol."},{"key":"1445_CR91","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","volume":"119","author":"AA Caudy","year":"2007","unstructured":"Caudy, A. A., Reddy, S. T., Chatila, T., Atkinson, J. P. & Verbsky, J. W. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J. Allergy Clin. Immunol. 119, 482\u2013487 (2007).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1445_CR92","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.4049\/jimmunol.1100272","volume":"188","author":"G Garg","year":"2012","unstructured":"Garg, G. et al. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function. J. Immunol. 188, 4644\u20134653 (2012).","journal-title":"J. Immunol."},{"key":"1445_CR93","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","volume":"146","author":"K Goudy","year":"2013","unstructured":"Goudy, K. et al. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin. Immunol. 146, 248\u2013261 (2013).","journal-title":"Clin. Immunol."},{"key":"1445_CR94","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1600-0854.2005.00294.x","volume":"6","author":"A d\u2019Azzo","year":"2005","unstructured":"d\u2019Azzo, A., Bongiovanni, A. & Nastasi, T. E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic 6, 429\u2013441 (2005).","journal-title":"Traffic"},{"key":"1445_CR95","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.smim.2007.02.003","volume":"19","author":"YC Liu","year":"2007","unstructured":"Liu, Y. C. The E3 ubiquitin ligase Itch in T cell activation, differentiation, and tolerance. Semin. Immunol. 19, 197\u2013205 (2007).","journal-title":"Semin. Immunol."},{"key":"1445_CR96","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature12199","volume":"498","author":"R Roychoudhuri","year":"2013","unstructured":"Roychoudhuri, R. et al. BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature 498, 506\u2013510 (2013).","journal-title":"Nature"},{"key":"1445_CR97","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","volume":"39","author":"EI Buchbinder","year":"2016","unstructured":"Buchbinder, E. I. & Desai, A. CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am. J. Clin. Oncol. 39, 98\u2013106 (2016).","journal-title":"Am. J. Clin. Oncol."},{"key":"1445_CR98","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaci.2014.10.019","volume":"135","author":"LM Charbonnier","year":"2015","unstructured":"Charbonnier, L. M. et al. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. J. Allergy Clin. Immunol. 135, 217\u2013227 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1445_CR99","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10875-017-0451-1","volume":"37","author":"FJ Alroqi","year":"2017","unstructured":"Alroqi, F. J. et al. DOCK8 deficiency presenting as an IPEX-like disorder. J. Clin. Immunol. 37, 811\u2013819 (2017).","journal-title":"J. Clin. Immunol."},{"key":"1445_CR100","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clim.2017.06.003","volume":"181","author":"CM Biggs","year":"2017","unstructured":"Biggs, C. M., Keles, S. & Chatila, T. A. DOCK8 deficiency: insights into pathophysiology, clinical features and management. Clin. Immunol. 181, 75\u201382 (2017).","journal-title":"Clin. Immunol."},{"key":"1445_CR101","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MPG.0000000000001262","volume":"64","author":"F Charbit-Henrion","year":"2017","unstructured":"Charbit-Henrion, F. et al. Deficiency in mucosa-associated lymphoid tissue lymphoma translocation 1: a novel cause of IPEX-like syndrome. J. Pediatr. Gastroenterol. Nutr. 64, 378\u2013384 (2017).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"1445_CR102","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/cdd.2015.104","volume":"24","author":"A Brustle","year":"2017","unstructured":"Brustle, A. et al. MALT1 is an intrinsic regulator of regulatory T cells. Cell Death Differ. 24, 1214\u20131223 (2017).","journal-title":"Cell Death Differ."},{"key":"1445_CR103","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"208","author":"L Liu","year":"2011","unstructured":"Liu, L. et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635\u20131648 (2011).","journal-title":"J. Exp. Med."},{"key":"1445_CR104","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","volume":"131","author":"G Uzel","year":"2013","unstructured":"Uzel, G. et al. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J. Allergy Clin. Immunol. 131, 1611\u20131623 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1445_CR105","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jaci.2016.11.022","volume":"139","author":"KG Weinacht","year":"2017","unstructured":"Weinacht, K. G. et al. Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation. J. Allergy Clin. Immunol. 139, 1629\u20131640 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1445_CR106","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","volume":"125","author":"EM Haapaniemi","year":"2015","unstructured":"Haapaniemi, E. M. et al. Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood 125, 639\u2013648 (2015).","journal-title":"Blood"},{"key":"1445_CR107","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","volume":"179","author":"TJ Harris","year":"2007","unstructured":"Harris, T. J. et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J. Immunol. 179, 4313\u20134317 (2007).","journal-title":"J. Immunol."},{"key":"1445_CR108","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","volume":"125","author":"JD Milner","year":"2015","unstructured":"Milner, J. D. et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 125, 591\u2013599 (2015).","journal-title":"Blood"},{"key":"1445_CR109","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.clim.2013.04.014","volume":"148","author":"JA Jenks","year":"2013","unstructured":"Jenks, J. A. et al. Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. Clin. Immunol. 148, 227\u2013236 (2013).","journal-title":"Clin. Immunol."},{"key":"1445_CR110","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fimmu.2012.00234","volume":"3","author":"T Kanai","year":"2012","unstructured":"Kanai, T., Jenks, J. & Nadeau, K. C. The STAT5b pathway defect and autoimmunity. Front. Immunol. 3, 234 (2012).","journal-title":"Front. Immunol."},{"key":"1445_CR111","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1126\/science.1075958","volume":"298","author":"MS Anderson","year":"2002","unstructured":"Anderson, M. S. et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 298, 1395\u20131401 (2002).","journal-title":"Science"},{"key":"1445_CR112","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.autrev.2017.11.012","volume":"17","author":"CJ Guo","year":"2018","unstructured":"Guo, C. J., Leung, P. S. C., Zhang, W., Ma, X. & Gershwin, M. E. The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1). Autoimmun. Rev. 17, 78\u201385 (2018).","journal-title":"Autoimmun. Rev."},{"key":"1445_CR113","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jaut.2010.07.008","volume":"35","author":"SM Laakso","year":"2010","unstructured":"Laakso, S. M. et al. Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population. J. Autoimmun. 35, 351\u2013357 (2010).","journal-title":"J. Autoimmun."},{"key":"1445_CR114","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jaci.2009.10.023","volume":"125","author":"B Cassani","year":"2010","unstructured":"Cassani, B. et al. Defect of regulatory T cells in patients with Omenn syndrome. J. Allergy Clin. Immunol. 125, 209\u2013216 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1445_CR115","doi-asserted-by":"crossref","unstructured":"Lee, Y. N. et al. Characterization of T and B cell repertoire diversity in patients with RAG deficiency. Sci. Immunol. 1, eaah6109 (2016).","DOI":"10.1126\/sciimmunol.aah6109"},{"key":"1445_CR116","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF00278938","volume":"57","author":"A de la Chapelle","year":"1981","unstructured":"de la Chapelle, A., Herva, R., Koivisto, M. & Aula, P. A deletion in chromosome 22 can cause DiGeorge syndrome. Hum. Genet. 57, 253\u2013256 (1981).","journal-title":"Hum. Genet."},{"key":"1445_CR117","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00125817-200101000-00006","volume":"3","author":"DM McDonald-McGinn","year":"2001","unstructured":"McDonald-McGinn, D. M. et al. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genet. Med. 3, 23\u201329 (2001).","journal-title":"Genet. Med."},{"key":"1445_CR118","first-page":"1129","volume":"9","author":"KE Sullivan","year":"2002","unstructured":"Sullivan, K. E., McDonald-McGinn, D. & Zackai, E. H. CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia. Clin. Diagn. Lab. Immunol. 9, 1129\u20131131 (2002).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"1445_CR119","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clim.2007.02.001","volume":"124","author":"M Adriani","year":"2007","unstructured":"Adriani, M. et al. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin. Immunol. 124, 41\u201348 (2007).","journal-title":"Clin. Immunol."},{"key":"1445_CR120","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1084\/jem.20061334","volume":"204","author":"F Marangoni","year":"2007","unstructured":"Marangoni, F. et al. WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J. Exp. Med. 204, 369\u2013380 (2007).","journal-title":"J. Exp. Med."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01445-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T03:03:43Z","timestamp":1675047823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01445-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1445"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01445-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"14 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}